The demise and death of VRTX Hep C drug has been known since it was released. In my opinion, there is no new news here. It would have been horrible if the new oral regimen failed. Horrible, but profitable for VRTX longs.
Time to move on has long past. Seems to me the market is overreacting. Imagine that.